JPH0216287B2 - - Google Patents

Info

Publication number
JPH0216287B2
JPH0216287B2 JP56142184A JP14218481A JPH0216287B2 JP H0216287 B2 JPH0216287 B2 JP H0216287B2 JP 56142184 A JP56142184 A JP 56142184A JP 14218481 A JP14218481 A JP 14218481A JP H0216287 B2 JPH0216287 B2 JP H0216287B2
Authority
JP
Japan
Prior art keywords
active ingredient
acid addition
group
allyl
oxazolo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP56142184A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5846092A (ja
Inventor
Korunerisu Ineme Hendorikusu
Konsutanteinusu Antoniusu Ban Meeru Yakobusu
De Yonge Adorian
Berunarudosu Maruteinusu Uiriburorudosu Maria Teimerumansu Petorusu
Adoriaan Banzuieten Pieteru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Priority to JP56142184A priority Critical patent/JPS5846092A/ja
Publication of JPS5846092A publication Critical patent/JPS5846092A/ja
Publication of JPH0216287B2 publication Critical patent/JPH0216287B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP56142184A 1981-09-09 1981-09-09 緑内障治療剤 Granted JPS5846092A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56142184A JPS5846092A (ja) 1981-09-09 1981-09-09 緑内障治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56142184A JPS5846092A (ja) 1981-09-09 1981-09-09 緑内障治療剤

Publications (2)

Publication Number Publication Date
JPS5846092A JPS5846092A (ja) 1983-03-17
JPH0216287B2 true JPH0216287B2 (da) 1990-04-16

Family

ID=15309326

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56142184A Granted JPS5846092A (ja) 1981-09-09 1981-09-09 緑内障治療剤

Country Status (1)

Country Link
JP (1) JPS5846092A (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180721A (en) * 1989-05-22 1993-01-19 Allergan, Inc. Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5281591A (en) * 1989-05-22 1994-01-25 Allergan, Inc. Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
US5252595A (en) * 1990-02-28 1993-10-12 Allergan, Inc. Method for reducing or maintaining intraocular pressure in the mammalian eye by administering pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenylamino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines
US5580892A (en) * 1993-10-22 1996-12-03 Allergan Method for using 2-(2-alkylphenylamino)-oxazolines as adrenergic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2820808A1 (de) * 1978-05-12 1979-11-22 Thomae Gmbh Dr K Arzneimittel mit einer antanginoesen wirksamkeit

Also Published As

Publication number Publication date
JPS5846092A (ja) 1983-03-17

Similar Documents

Publication Publication Date Title
Miller et al. Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits
US6458842B1 (en) Liquid pharmaceutical compositions comprising thyroid hormones
US5795913A (en) Ophthalmic composition
FI78235B (fi) Foerfarande foer framstaellning av en topisk anti-inflammatorisk komposition i gelsalvaform.
JPH06239748A (ja) セチリジン含有抗アレルギー点眼点鼻用組成物
KR20000049281A (ko) 히알루론산과 국소 마취제의 염으로 이루어진 약제
HK27894A (en) Preservative system for ophtalmic formulations
CZ290987B6 (cs) Oční přípravek se sníľenou viskozitou
EP2163548A1 (en) Prophylactic or therapeutic agent for age-related macular degeneration
TW304167B (da)
DE69715228T2 (de) Einen carboanhydrase-hemmer und xanthangummi enthaltendes augenarzneimittel
US4440778A (en) Anti-inflammatory analgesic cataplasm and process for producing the same
US5049587A (en) Ophthalmic solution for intraocular pressure adjustment
AU674335B2 (en) Ophthalmological preparation
CN101083984A (zh) 用于经鼻内投与酮咯酸（ketorolac）的治疗组合物
AU781828B2 (en) Dosing regimens for lasofoxifene
RS67054B1 (sr) Oftalmološke kompozicije koje sadrže prostamid koji oslobađa azotni oksid
KR102657652B1 (ko) 눈 통증의 예방 및 치료를 위한 아미노포스핀산 유도체
TW487573B (en) Pharmaceutical compositions for reducing ocular pressure
WO2023016583A1 (zh) 一种芦可替尼组合物及其用途
RU2038076C1 (ru) Местно-анестезирующее средство для глаз
US4400378A (en) Pharmaceutical composition for the treatment of glaucoma
JPS5846092A (ja) 緑内障治療剤
US4623664A (en) Oil suspended phenylephrine
PL172503B1 (pl) Oftalmiczny srodek do podawania miejscowego zawierajacy pólwodzian (S)-tymololu PL PL PL PL